First Time Loading...

AlzChem Group AG
XETRA:ACT

Watchlist Manager
AlzChem Group AG Logo
AlzChem Group AG
XETRA:ACT
Watchlist
Price: 46.7 EUR 1.3% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

AlzChem Group AG engages in the development, production, and marketing of chemical products. [ Read More ]

The intrinsic value of one ACT stock under the Base Case scenario is 50.43 EUR. Compared to the current market price of 46.7 EUR, AlzChem Group AG is Undervalued by 7%.

Key Points:
ACT Intrinsic Value
Base Case
50.43 EUR
Undervaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
AlzChem Group AG

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ACT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
AlzChem Group AG

Provide an overview of the primary business activities
of AlzChem Group AG.

What unique competitive advantages
does AlzChem Group AG hold over its rivals?

What risks and challenges
does AlzChem Group AG face in the near future?

Summarize the latest earnings call
of AlzChem Group AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AlzChem Group AG.

Provide P/S
for AlzChem Group AG.

Provide P/E
for AlzChem Group AG.

Provide P/OCF
for AlzChem Group AG.

Provide P/FCFE
for AlzChem Group AG.

Provide P/B
for AlzChem Group AG.

Provide EV/S
for AlzChem Group AG.

Provide EV/GP
for AlzChem Group AG.

Provide EV/EBITDA
for AlzChem Group AG.

Provide EV/EBIT
for AlzChem Group AG.

Provide EV/OCF
for AlzChem Group AG.

Provide EV/FCFF
for AlzChem Group AG.

Provide EV/IC
for AlzChem Group AG.

Show me price targets
for AlzChem Group AG made by professional analysts.

What are the Revenue projections
for AlzChem Group AG?

How accurate were the past Revenue estimates
for AlzChem Group AG?

What are the Net Income projections
for AlzChem Group AG?

How accurate were the past Net Income estimates
for AlzChem Group AG?

What are the EPS projections
for AlzChem Group AG?

How accurate were the past EPS estimates
for AlzChem Group AG?

What are the EBIT projections
for AlzChem Group AG?

How accurate were the past EBIT estimates
for AlzChem Group AG?

Compare the revenue forecasts
for AlzChem Group AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AlzChem Group AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AlzChem Group AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of AlzChem Group AG compared to its peers.

Compare the P/E ratios
of AlzChem Group AG against its peers.

Discuss the investment returns and shareholder value creation
comparing AlzChem Group AG with its peers.

Analyze the financial leverage
of AlzChem Group AG compared to its main competitors.

Show all profitability ratios
for AlzChem Group AG.

Provide ROE
for AlzChem Group AG.

Provide ROA
for AlzChem Group AG.

Provide ROIC
for AlzChem Group AG.

Provide ROCE
for AlzChem Group AG.

Provide Gross Margin
for AlzChem Group AG.

Provide Operating Margin
for AlzChem Group AG.

Provide Net Margin
for AlzChem Group AG.

Provide FCF Margin
for AlzChem Group AG.

Show all solvency ratios
for AlzChem Group AG.

Provide D/E Ratio
for AlzChem Group AG.

Provide D/A Ratio
for AlzChem Group AG.

Provide Interest Coverage Ratio
for AlzChem Group AG.

Provide Altman Z-Score Ratio
for AlzChem Group AG.

Provide Quick Ratio
for AlzChem Group AG.

Provide Current Ratio
for AlzChem Group AG.

Provide Cash Ratio
for AlzChem Group AG.

What is the historical Revenue growth
over the last 5 years for AlzChem Group AG?

What is the historical Net Income growth
over the last 5 years for AlzChem Group AG?

What is the current Free Cash Flow
of AlzChem Group AG?

Financials

Balance Sheet Decomposition
AlzChem Group AG

Current Assets 216.6m
Cash & Short-Term Investments 11.9m
Receivables 97.2m
Other Current Assets 107.5m
Non-Current Assets 208.1m
Long-Term Investments 6k
PP&E 182.1m
Intangibles 3.7m
Other Non-Current Assets 22.3m
Current Liabilities 82.6m
Accounts Payable 31.6m
Other Current Liabilities 51.1m
Non-Current Liabilities 180.4m
Long-Term Debt 52m
Other Non-Current Liabilities 128.4m
Efficiency

Earnings Waterfall
AlzChem Group AG

Revenue
540.6m EUR
Cost of Revenue
-232.6m EUR
Gross Profit
308.1m EUR
Operating Expenses
-251m EUR
Operating Income
57.1m EUR
Other Expenses
-22.5m EUR
Net Income
34.6m EUR

Free Cash Flow Analysis
AlzChem Group AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

ACT Profitability Score
Profitability Due Diligence

AlzChem Group AG's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive ROE
Positive Revenue Growth Forecast
55/100
Profitability
Score

AlzChem Group AG's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

ACT Solvency Score
Solvency Due Diligence

AlzChem Group AG's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Short-Term Solvency
Long-Term Solvency
66/100
Solvency
Score

AlzChem Group AG's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACT Price Targets Summary
AlzChem Group AG

Wall Street analysts forecast ACT stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACT is 37.1 EUR with a low forecast of 29.29 EUR and a high forecast of 42 EUR.

Lowest
Price Target
29.29 EUR
37% Downside
Average
Price Target
37.1 EUR
21% Downside
Highest
Price Target
42 EUR
10% Downside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

ACT Price
AlzChem Group AG

1M 1M
+42%
6M 6M
+134%
1Y 1Y
+158%
3Y 3Y
+104%
5Y 5Y
+156%
10Y 10Y
+892%
Annual Price Range
46.7
52w Low
17.8
52w High
46.7
Price Metrics
Average Annual Return -1.08%
Standard Deviation of Annual Returns 13.45%
Max Drawdown -43%
Shares Statistics
Market Capitalization 475.2m EUR
Shares Outstanding 10 176 300
Percentage of Shares Shorted
N/A

ACT Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

AlzChem Group AG Logo
AlzChem Group AG

Country

Germany

Industry

Chemicals

Market Cap

475.2m EUR

Dividend Yield

2.57%

Description

AlzChem Group AG engages in the development, production, and marketing of chemical products. The company is headquartered in Trostberg, Bayern and currently employs 1,636 full-time employees. The Group's operating business is divided into three segments: Specialty Chemicals, Basics & Intermediates and Other & Holding. Its products can be applied in areas, such as nutrition, renewable energy, fine chemicals, agriculture and metallurgy. The firm produces dietary supplements; epoxy resin hardeners for use in adhesives, powder coatings, printed circuit boards and composites; silicon nitride for advanced ceramics and solar wafers; technical gases; specialty fertilizer, germicide for use in pig pens, plant growth regulators and plant protection additives, among others. The company also provides related services. The firm operates production sites in Germany and Sweden, a sales subsidiary in the United States and a Chinese subsidiary for the purchase of raw materials and distribution in Asia.

Contact

BAYERN
Trostberg
Chemiepark Trostberg, Dr. Albert-Frank-Str. 32
+498621860.0
https://www.alzchem.com/de

IPO

1999-06-01

Employees

1 636

Officers

CEO & Chairman of Executive Board
Mr. Andreas Niedermaier
Member of Executive Board & COO
Mr. Klaus Dieter Englmaier
Chief Sales Officer & Member of Executive Board
Dr. Georg Weichselbaumer
CFO & Member of Management Board
Mr. Andreas Losle

See Also

Discover More
What is the Intrinsic Value of one ACT stock?

The intrinsic value of one ACT stock under the Base Case scenario is 50.43 EUR.

Is ACT stock undervalued or overvalued?

Compared to the current market price of 46.7 EUR, AlzChem Group AG is Undervalued by 7%.